Transphorm’s rights offering raises $7.94m Transphorm Inc of Goleta, near Santa Barbara, CA, USA — which designs and manufactures  JEDEC- and AEC-Q101-qualified gallium nitride  (GaN) field-effect transistors (FETs) for high-voltage power conversion —says that its rights offering (announced on 16 June), which entitled eligible stockholders to purchase  0.07655623 of a share of common stock for every right held at a  subscription price of $3.30 per whole share, has resulted in the sale of  2,404,758 shares, generating about $7.94m in gross proceeds. After giving  effect to the rights offering, the firm has about 61.8 million shares of  common stock issued and outstanding. KKR Phorm Investors L.P. exercised in full its basic  subscription rights in the rights offering. In addition, all executive officers  and certain directors of the company each acquired shares in the offering.  Updated positions of their shares held will be disclosed via Form 4  filings with the US Securities and Exchange Commission (SEC). “With the completion of the rights offering, Transphorm is now  well positioned to begin a review of strategic opportunities and alternatives  for enhancing and maximizing stockholder value including, but not be limited  to, strategic partnerships, licensing opportunities in the USA and Asia, and  potential M&A opportunities,” says Transphorm’s president, CEO &  co-founder Primit Parikh. 